SM
CLVS

Sabby Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sabby Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-420
Closed -$1.87M – 337
2016
Q4 		$1.87M Sell
420
-1,671
-80% -$58.8K 0.11% 108
2016
Q3 		$7.54M Buy
2,091
+1,988
+1,930% +$42.7K 0.28% 52
2016
Q2 		$141K Buy
103
+3
+3% +$44 0.01% 259
2016
Q1 		$192K Buy
+100
New +$2.12K 0.01% 259
2014
Q3 		– Sell
-206
Closed -$853K – 309
2014
Q2 		$853K Sell
206
-794
-79% -$40.9K 0.04% 163
2014
Q1 		$6.93M Buy
+1,000
New +$73.4K 0.39% 52

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return